|
|
||||||||
Departamento de Medicina Social, Faculdade de Medicina, Universidade Federal de Pelotas, Brazil.
Vitamin K prophylaxis prevents hemorrhagic disease of the newborn. The present review estimates the potential magnitude of this problem in less developed countries, assessing the need for prophylaxis, along with its cost-effectiveness and feasibility. Late hemorrhagic disease, occurring between 2 and 12 weeks, often leads to death or permanent disability. Its median incidence in developed countries is 7 per 100,000 births. Incidences in less developed countries may be much higher. Three incidence scenarios are proposed and the corresponding losses of disability-adjusted life-years (DALYs) calculated. Under the intermediate scenario, late hemorrhagic disease accounts for 0.1% to 0.2% of DALYs lost to children less than 5 years of age. Assuming a cost of +1.00 per injection, each DALY saved would cost +133. Decisions on prophylaxis must be made on a national basis, considering mortality levels and causes, health budgets, and feasibility. Comparison with the impact of diseases prevented by breast-feeding shows that concern with hemorrhagic disease should not affect breast-feeding promotion efforts, although strategies for supplementing breast-fed infants must be explored.
This article has been cited by other articles:
![]() |
Z. A. Bhutta, G. L. Darmstadt, B. S. Hasan, and R. A. Haws Community-Based Interventions for Improving Perinatal and Neonatal Health Outcomes in Developing Countries: A Review of the Evidence Pediatrics, February 1, 2005; 115(2/S1): 519 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Danielsson, D P Hoa, N V Thang, T Vos, and P M Loughnan Intracranial haemorrhage due to late onset vitamin K deficiency bleeding in Hanoi province, Vietnam Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2004; 89(6): F546 - F550. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |